Interleukin 1 (IL-1) is an important mediator of innate immunity but can also promote inflammatory tissue damage. During chronic infections such as tuberculosis, the beneficial antimicrobial role of IL-1 must be balanced with the need to prevent immunopathology. By exogenously controlling the replication of Mycobacterium tuberculosis in vivo, we obviated the requirement for antimicrobial immunity and discovered that both IL-1 production and infection-induced immunopathology were suppressed by lymphocyte-derived interferon-g (IFN-g). This effect was mediated by nitric oxide (NO), which we found specifically inhibited assembly of the NLRP3 inflammasome via thiol nitrosylation. Our data indicate that the NO produced as a result of adaptive immunity is indispensable in modulating the destructive innate inflammatory responses elicited during persistent infections.
Inflammation is a tightly regulated process, and multiple signals must be integrated by the innate immune system to determine if this reaction will be initiated. This coordination is particularly apparent in the pathway that controls the proinflammatory cytokine interleukin 1β (IL-1β). Transcription of the gene encoding the IL-1β precursor pro-IL-1β is induced through the ligation of pattern-recognition receptors, such as Toll-like receptors (TLRs), that recognize conserved microbial structures. The subsequent processing of the precursor peptide into its active form is mediated by multiprotein complexes called 'inflammasomes' 1 . These hetero-oligomeric structures consist of the IL-1β-processing enzyme caspase-1, the adaptor ASC and a sensor protein of the Nod-like receptor or AIM2-like receptor family. Depending on the associated sensor protein, inflammasome assembly and proteolytic activation of caspase-1 can be initiated either by the recognition of microbial patterns or through the perception of host-cell injury. Thus, IL-1β production is controlled through the coordination of signals derived from both the presence of microbial colonization and the damage induced by the pathogen 2 .
The resulting inflammatory reaction is characterized by intravascular coagulation, tissue edema and neutrophil infiltration. IL-1 can both initiate and propagate this response by regulating the adhesion of leukocytes to the vascular endothelium and by inducing the production of secondary chemokines that direct the chemotaxis of neutrophils to the site of tissue damage 3 . The coordinated action of these responses is generally able to eradicate the eliciting infection, and IL-1 is critically required for resistance to many bacterial and fungal pathogens 4, 5 . However, this resistance comes at the cost of substantial damage to the host tissue, as activated phagocytes release hydrolytic enzymes and reactive oxygen radicals that are equally toxic to host cells and microbial cells 6 . Thus, when the innate immune response is able to eliminate a pathogen, the resulting self-limiting inflammation is clearly beneficial. However, in the context of persistent infections, it is unclear how the potentially destructive aspects of the IL-1-initiated inflammatory response are controlled to preserve tissue integrity.
A classic example of the paradox noted above is tuberculosis, a chronic infection caused by Mycobacterium tuberculosis. Mycobacterial cells are the basis of the most effective immunological adjuvants and are among the most immunostimulatory particles known 7, 8 . Not unexpectedly, pulmonary infection with this pathogen initially elicits robust induction of IL-1 and influx of neutrophils 9 in the mouse, but this response is essentially ineffective in controlling the infection 10 . Bacterial replication begins to slow only with the onset of adaptive immunity. At this point, interferon-γ (IFN-γ) produced by newly recruited lymphocytes acts on the parasitized macrophages to trigger the expression of antimicrobial effectors, including the inducible isoform of nitric oxide synthase (iNOS). The resulting nitric oxide (NO) inhibits bacterial growth 11 , but even this adaptive immune response does not diminish the number of viable bacteria. In both mouse and nonhuman-primate models of tuberculosis, a relatively large bacterial burden is maintained for months or even years before disease becomes apparent 12, 13 . The ability of the host to sustain the persistent presence of this immunostimulatory pathogen in its lungs suggests that the regulatory circuits that control inflammation are important for maintaining tissue integrity during this asymptomatic period.
Active tuberculosis disease eventually afflicts approximately 10% of infected people, which results in millions of deaths each year. This disease is generally thought to progress as a result of increased M. tuberculosis replication in the tissue. However, bacterial burden is not strictly correlated with disease progression in various inbred mouse strains 14 , and several hallmarks of severe tuberculosis disease suggest that insufficiently controlled innate inflammation has an important role in pathogenesis. For example, neutrophil accumulation is evident in active tuberculosis lesions of both humans 15 and mice 16 . Furthermore, both the IL-1-processing inflammasome complex and neutrophil infiltration have been shown to contribute to the pathology caused by the related pathogen Mycobacterium marinum 17 . Therefore, the ability of an organism to modulate tissue-damaging inflammatory responses may be a distinct determinant of the progression of tuberculosis disease independent of bacterial burden.
The presence of IFN-γ-producing T cells is inversely correlated with pathology in M. tuberculosis-infected mice 18 , and this cytokine has anti-inflammatory properties in both infection 19 and autoimmuneinduced disease models 20 . Such observations indicate that the adaptive immune response might be responsible for suppressing innate inflammatory pathways during persistent infection with M. tuberculosis. To specifically characterize these putative immunoregulatory roles, we rendered antimicrobial functions unnecessary by deliberately controlling the replication of M. tuberculosis in vivo. We found that the same immunological axis critical for restricting bacterial replication, IFN-γ and NO, was also necessary to suppress the continual production of IL-1β by the NLRP3 inflammasome, to inhibit persistent neutrophil recruitment and to prevent progressive tissue damage. Our findings indicate an unanticipated dual role for NO in promoting resistance to M. tuberculosis and that both its antimicrobial activity and the immunoregulatory function we describe are needed for the host to survive this chronic infection.
RESULTS

Adaptive immunity influences IL-1 production
To investigate the potential role of adaptive immunity in regulating innate inflammatory pathways, we examined the mechanisms that drive the pathogenesis of tuberculosis in mice that lack mature T lymphocytes and B lymphocytes (Rag2 −/− mice), IFN-γ (Ifng −/− mice) or iNOS (Nos2 −/− mice). After infection with M. tuberculosis, each of these mutant mouse strains rapidly developed a disease qualitatively different from that of wild-type C57BL/6 mice. Although the lesions observed in immunocompetent (C57BL/6) mice were largely histocytic, lesions in the mutant mice were pygranulomatous and characterized by extensive tissue necrosis, neutrophil infiltration and relatively high bacterial burdens (Fig. 1a-c) . This severe pathology was associated with a distinct cytokine signature (Fig. 1d,e) dominated by IL-1α, IL-1β and several monocyte-granulocyte chemoattractants known to be induced by IL-1, such as the chemokines CCL2 (MCP-1), CCL3 (MIP-1α) and CCL4 (MIP-1β). Although lung homogenates of Nos2 −/− mice had relatively large amounts of the immature 31-kilodalton precursor of IL-1β, accumulation of the mature active form of IL-1β (p17) was even greater. The ratio of mature IL-1β to immature IL-1β was sevenfold higher in Nos2 −/− mice than in wild-type (C57BL/6) mice (Fig. 1f) , which suggested that the processing of IL-1β was enhanced in the mutant mice. Consistent with the apparently greater maturation of IL-1β, the active form of caspase-1 (assessed as the p10 fragment) was detectable in the lungs of Nos2 −/− mice but not those of wild type mice (Fig. 1f) .
Although Rag2 −/− , Ifng −/− and Nos2 −/− mice consistently produced relatively large amounts of mature IL-1β and related chemokines, the abundance of many other cytokines characteristic of both innate and adaptive immune responses was either diminished or unchanged (Fig. 1d) . This relatively specific alteration in cytokine profile suggested that IFN-γ-dependent NO might serve a specific role in modulating IL-1β responses. However, the immunodeficient mice lacking this important antimicrobial pathway had 30-to 200-fold more bacteria in their lungs at the time of analysis than did wild-type mice (Fig. 1c) , and we were unable to exclude the possibility that this greater bacterial burden caused the observed differences in cytokine amounts and pathology.
NO directly modulates IL-1 responses and immunopathology
To more directly determine if NO regulated IL-1β and inflammation, we developed an infection model that uses a 16S rRNA-mutant of M. tuberculosis (strain 18b) that replicates only in the presence of streptomycin 21, 22 . Our ability to exogenously control bacterial replication allowed us to maintain the same number of bacteria in wild-type and Nos2 −/− mice throughout infection. To colonize the lungs with a physiologically relevant burden of these relatively slow-growing bacteria, we inoculated mice either intratracheally or intravenously. After infecting the mice, we administered streptomycin to them for 14 d, then arrested bacterial replication via drug withdrawal (Fig. 2a) . We found that 22 d later, all mice had similar numbers of M. tuberculosis in their lungs and spleens (Fig. 2b) . However, the disease observed in these two mouse strains was profoundly different, and the Nos2 −/− mice infected by the intratracheal route became moribund by day 36. Nos2 −/− mice had more local inflammatory pathology regardless of the route of infection, as the tissue architecture of both the lungs and spleens was disrupted by leukocyte infiltration. These mice also suffered significant wasting (Fig. 2c,d) , consistent with an enhanced systemic inflammatory response.
The cellular composition and cytokine profile of lesions in Nos2 −/− mice were distinct from those of their wild-type counterparts and were consistent with an IL-1-mediated inflammatory disease. By flow cytometry, we found that the airways and dissociated lung tissue of the Nos2 −/− mice had more neutrophils (CD11b + Gr-1 hi ), whereas T cell infiltration (CD3 + ) increased to a lesser degree. We confirmed the enhanced recruitment of neutrophils by quantifying myeloperoxidase activity in lung homogenates (Fig. 2e,f) . This granulocytic infiltration was associated with an IL-1β-dominated cytokine signature similar to that observed in mice infected with wild-type bacteria, and the active proteolytic fragment of IL-1β was present only in lysates of Nos2 −/− lungs (Fig. 2g,h) . In contrast to the production of IL-1β and related chemokines, the production of a distinct proinflammatory mediator, IL-6, was correlated with bacterial burden and not with NO production itself (Figs. 1d and 2g) . Together these data suggested that NO modulated immunopathology independently of its role in restricting M. tuberculosis growth and that IFN-γ-stimulated NO had a specific role in regulating the expression and maturation of IL-1β.
Exacerbated pathology depends on IL-1 and ASC The coincident enhancement of both IL-1β and neutrophil infiltration in Nos2 −/− mice suggested that this cytokine might have a causal role in the observed immunopathology. To test this hypothesis, we infected wild-type mice and mice deficient in the receptor for IL-1 (Il1r1 −/− mice) with M. tuberculosis and quantified the influx of neutrophils into the lung after treating the mice with the A r t i c l e s npg A r t i c l e s iNOS inhibitor aminoguanidine hemisulfate (AGHS). To ensure that differences in bacterial growth did not influence inflammation, we used the streptomycin-dependent infection model described above. Similar to our observations obtained with Nos2 −/− mice, treatment with AGHS resulted in more recruitment of neutrophils into the lungs of wild-type mice, as assessed by both flow cytometry and myeloperoxidase assay. This cellular recruitment was abrogated in Il1r1 −/− mice (Fig. 3a) , which demonstrated that the exacerbated inflammatory response noted in Nos2 −/− mice depended on IL-1 signaling and not on related cytokines such as IL-18.
IL-1β maturation seemed to be altered by NO (Fig. 1f) , but the protease(s) responsible for this event in vivo remained unclear. Caspase-1-containing inflammasome complexes are absolutely required for the maturation of IL-1β in M. tuberculosis-infected macrophages in vitro 23, 24 . However, the cell types that produce IL-1β in vivo might be distinct 25 , and inflammasome-independent mechanisms seem to dominate in immunocompetent mice chronically infected with M. tuberculosis 26 . To determine if the inflammasome was required for the enhanced IL-1β activity we observed after inhibition of iNOS, we assessed the role of the inflammasome complex in M. tuberculosis-induced inflammation. After being infected with streptomycin-dependent M. tuberculosis, ASC-deficient mice and wild type mice accumulated similar numbers of neutrophils in their lungs. However, the enhanced recruitment of neutrophils observed after treatment with AGHS was reversed in ASC-deficient mice (Fig. 3b) . This phenotype was very similar to that seen in Il1r1 −/− mice. Thus, the immunopathology observed after iNOS inhibition was caused by inflammasome-dependent IL-1.
IFN-g suppresses IL-1b in M. tuberculosis-infected macrophages
We investigated the mechanisms by which IFN-γ and NO regulated IL-1β in M. tuberculosis-infected macrophages. Consistent with published reports 23, 24 , IL-1β production in response to infection with M. tuberculosis depended on the NLRP3-ASC-caspase-1 complex and was probably secondary to membrane damage mediated by the bacterial ESX1 secretion system ( Supplementary Fig. 1a,b) . As we predicted on the basis of our in vivo observations, pretreatment of M. tuberculosis-infected macrophages with IFN-γ specifically inhibited the release of IL-1β but had no effect on the production of the unrelated cytokine tumor-necrosis factor (TNF). This suppression required signaling through IFN-γ receptor 1, was independent of IFN-γ produced by the macrophages (Fig. 4a,b ) and required stimulation with IFN-γ before infection (Supplementary Fig. 1c ). Pretreatment with IFN-γ did not affect bacterial uptake or diminish the viability Fig. 2a,b) , which suggested a direct effect on IL-1β production. By many criteria, IFN-γ seemed to suppress the inflammasomedependent maturation of IL-1 and not the expression of this cytokine's proform. By immunoblot analysis, we found that IFN-γ did not affect the abundance of pro-IL-1β in cell lysates but specifically inhibited the processing and release of mature IL-1β into the supernatant (Fig. 4c) . Furthermore, suppression by IFN-γ was equally apparent whether pro-IL1β expression was induced by M. tuberculosis alone or by prestimulation with the TLR2 ligand Pam 3 CSK 4 , the TLR4 ligand lipopolysaccharide (LPS) or the TLR3 ligand poly(I:C) (Fig. 4a,d) . Finally, release of IL-1α, which is regulated by inflammasome-dependent caspase-1 signaling 27 , was similarly suppressed by IFN-γ (Fig. 4d) , which further indicated that IFN-γ modulated inflammasome activity.
IFN-g specifically inhibits NLRP3 inflammasome activity
By treating macrophages with defined inflammasome activators, we found that the suppressive effect of IFN-γ was specific to the NLRP3 inflammasome. The NLRP3-dependent processing and release of IL-1β in response to the pore-forming toxin nigericin 28 was inhibited by pretreatment with IFN-γ (Fig. 5a,b) . In contrast, IFN-γ had no effect on IL-1β production in response to the B-form double-stranded DNA poly(dA:dT) (Fig. 5a,b) , which depends on the distinct AIM2-containing inflammasome 29 . As we observed with M. tuberculosisinfected macrophages, IFN-γ specifically suppressed the processing of IL-1β and did not affect the secretion of TNF induced after priming with LPS (Fig. 5a,b) .
Bacteria with distinct cellular structures or pathogenic strategies trigger different inflammasome complexes. Those that disrupt cellular membranes generally act on the NLRP3 complex, and those that express flagellin (or similar proteins) are able to trigger the NLRC4 inflammasome 30 . To determine if IFN-γ suppression was NLRP3 specific in the context of these more complex stimulants, we infected macrophages with pathogens that engage different inflammasomes. Consistent with published studies 31 , NLRP3 was the main Nod-like receptor required for M. marinum-induced IL-1β production, and NLRC4 dominated the response to Salmonella typhimurium 32 (Fig. 5c) . After treatment with IFN-γ, only the NLRP3-dependent production of IL-1β induced by infection with M. marinum was efficiently suppressed (Fig. 5d) . Thus, even in the context of genuine bacterial infection, IFN-γ specifically suppressed NLRP3-dependent responses.
IFN-g stimulated NO suppresses IL-1b maturation
Our in vivo observations suggested that the suppression of IL-1β processing by IFN-γ might rely on NO production. Indeed, deletion of Nos2 restored the processing and release of IL-1β in IFN-γ-treated macrophages infected with M. tuberculosis (Fig. 6a,b) . Chemical inhibition of the enzymatic activity of iNOS through the use of aminoguanidine 33 also abrogated the ability of IFN-γ to suppress the secretion of IL-1β (Fig. 6c) , which indicated that NO was the mediator of this inhibitory effect. Similarly, the direct addition of NO donors, such as SNAP (S-nitroso-N-acetyl-DL-penicillamine) and GSNO (S-nitrosoglutathione), inhibited the processing and release of 
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A r t i c l e s IL-1β as efficiently as did the addition of IFN-γ (Fig. 6d,e) . These donors produced a modestly lower total amount of nitrite than that in IFN-γ-treated macrophages over the time course of the experiment ( Supplementary Fig. 3a,b) and did not alter the secretion of TNF, which indicated that we had applied nontoxic doses. Consistent with the freely diffusible nature of NO, wild-type macrophages were able to suppress the production of IL-1β from cocultured iNOS-deficient cells in trans (Fig. 6f) . We concluded that NO was necessary for IFN-γ to suppress IL-1β and was sufficient to mediate this effect.
NO inhibits assembly of the NLRP3 inflammasome NO is able to regulate gene expression by inducing the synthesis of cyclic GMP 34 , which suggested that this compound might act by altering the abundance of inflammasome components. However, IFN-γ did not appreciably alter expression of the relevant inflammasome proteins NLRP3, ASC, caspase-1 or pro-IL-1β in cell lysates (data not shown). Furthermore, the cell membrane-permeable cyclic GMP analog 8-bromo-cGMP had no effect on the release of IL-1β when added to macrophage cultures before or during infection with M. tuberculosis ( Supplementary Fig. 4 ). The observations reported above suggested that that NO might act post-translationally to regulate inflammasome function. To investigate this possibility, we reconstituted the relevant protein complexes in 293T human embryonic kidney cells. Coexpression of NLRP3 (or AIM2), ASC, caspase-1 and pro-IL-1β in this heterologous system resulted in the spontaneous processing of both caspase-1 and IL-1β. The addition of an NO donor (SNAP) inhibited the NLRP3-dependent maturation of IL-1β in those transfected cells but had no effect on the AIM2 inflammasome (Fig. 7a) , which indicated that this compound might directly modulate the assembly or activity of the NLRP3 inflammasome.
To determine if NO altered inflammasome assembly, we evaluated the oligomerization of ASC that occurs during the formation of the NLRP3 inflammasome 35 . We isolated intact inflammasomes from stimulated macrophages by differential centrifugation, crosslinked the inflammasome components and detected these stable complexes by immunoblot analysis. The addition of either IFN-γ or SNAP to these cells inhibited formation of the ASC and caspase-1 oligomers induced by the NLRP3 stimulant nigericin. This inhibition of assembly correlated with a lack of maturation of caspase-1 into its A r t i c l e s processed 35-kilodalton form (Fig. 7b) . In contrast, IFN-γ and NO had little effect on the AIM2-dependent oligomerization of ASC and caspase-1 in response to poly(dA:dT) or the subsequent maturation of caspase-1. Thus, in both macrophages and transfected 293T cells, NO specifically inhibited the assembly and activity of the NLRP3 inflammasome complex.
NO regulates inflammasome activity via S-nitrosylation
In addition to its gene-regulatory roles, NO is also able to directly alter protein function through the chemical modification of cysteine residues 36 . To determine if the observed NO-dependent regulation of inflammasome activity was due to S-nitrosylation, we chemically reversed such modifications with ascorbate. This mild reductant abrogates the nitrosylation of thiols without affecting the ability to form disulfide bonds 37 . Treatment with ascorbate had no effect on the production of NO by macrophages but reversed the IFN-γ-mediated inhibition of IL-1β release in a dose-dependent manner (Fig. 7c) .
The processing of both IL-1β and caspase-1 was fully restored by this treatment, which indicated that the IFN-γ-and NO-mediated suppression of inflammasome activity relied on S-nitrosylation. The post-translational effect of NO on the assembly and activity of the inflammasome indicated that this protein complex might be directly modified by S-nitrosylation. Through the use of the 'biotinswitch' method 38 , we labeled S-nitrosocysteines in macrophage lysates with biotin and isolated the associated proteins with streptavidin. After stimulating M. tuberculosis-infected macrophages with IFN-γ, we detected iNOS-dependent nitrosylation of a variety of cellular proteins (Fig. 7d) . This nitrosylated protein fraction contained NLRP3 and caspase-1 but not AIM2 or ASC.
The S-nitrosylation of NLRP3 and caspase-1 suggested that modification of one or both of these proteins might be responsible for the inhibition of IL-1β processing. Indeed, nitrosylation of the caspase-1 active-site thiol has been proposed to regulate the proteolytic activity of this enzyme 39 . To identify the relevant cellular target(s) of NO, we 
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A r t i c l e s developed a reconstituted IL-1β-processing system in which NLRP3 or caspase-1 was expressed individually in separate 293T cell cultures and could be independently modified with NO donors. We incubated the resultant cell lysates (containing either NLRP3 or caspase-1) with lysates of cells transfected to express the remaining inflammasome components and detected IL-1β processing only when NLRP3, ASC, caspase-1 and pro-IL-1β were present simultaneously. This ability to reconstitute a functional inflammasome from separately produced components afforded us the opportunity to assess the specific effects of nitrosylation on either NLRP3 or caspase-1. The treatment of NLRP3-expressing cells with SNAP efficiently inhibited the IL-1β-processing activity of mixed lysates, whereas the treatment of caspase-1-expressing cells with SNAP had no effect on IL-1β processing at any noncytotoxic concentration (Fig. 7e) . To further investigate the effect of NO on caspase-1 activity, we determined the effect of SNAP treatment on the small amount of caspase-1 autoprocessing observed after overexpression of this protein alone in 293T cells. At concentrations that inhibited NLRP3-dependent maturation of caspase-1, SNAP had no effect on caspase-1 autoprocessing (Supplementary Fig. 5 ). Together these observations indicated that nitrosylation of NLRP3, but not of caspase-1, was sufficient to suppress inflammasome activity. We propose that NO-mediated inflammasome inhibition represents an important mechanism by which the adaptive immune response prevents persistent inflammatory tissue damage during chronic infection (Supplementary Fig. 6 ).
DISCUSSION
The observations we have described here have established a mechanism whereby IFN-γ-induced NO inhibits NLRP3-dependent IL-1 responses. To specifically investigate the importance of this regulatory effect, we developed a new animal model of tuberculosis that obviates the need for antimicrobial immunity. With this model, we found that NO-mediated IL-1 suppression promoted resistance to M. tuberculosis by modulating the inflammatory pathology caused by persistent infection with this pathogen.
Together, the post-translational inhibition of inflammasome assembly, the presence of nitrosylated inflammasome components and the restoration of IL-1β production by ascorbate indicated that NO modulated inflammasome activity via thiol nitrosylation. Although we detected the S-nitrosylation of both NLRP3 and caspase-1, three lines of evidence indicated that only the former represented a plausible target of regulation. First, the ability of IFN-γ or NO to specifically Fig. 1f ; lanes correspond to graph above). *P < 0.05 and **P < 0.01 (Student's t-test). npg inhibit the NLRP3 inflammasome and not other caspase-1 containing complexes indicated that caspase-1 was unlikely to be a functional nitrosylation target in this context. Second, IFN-γ and NO inhibited the oligomerization of ASC in nigericin-stimulated macrophages, a process that is independent of caspase-1 (ref. 40) . Finally, we found that nitrosylation of NLRP3 suppressed the processing of IL-1β by reconstituted inflammasomes, but nitrosylation of caspase-1 did not. Thus, we conclude that the reported nitrosylation of the active site of caspase-1 (ref. 39 ) was probably not involved in the process we have described. Instead, the most likely target of S-nitrosylation was the NLRP3 protein itself, although we cannot exclude the possibility of a contribution by an NLRP3-specific cofactor. NLRP3 is extremely rich in cysteine residues clustered in the leucine-rich repeat region proposed to be the sensing domain of the protein 41 . Identifying which of those 43 cysteine residues are functional targets of S-nitrosylation may prove to be an effective way of defining the repeats most important for triggering IL-1β responses.
The mechanism by which NO modulates the inflammasome is conceptually similar to the inhibition of IL-1 processing mediated by the superoxide radical. This compound promotes the glutathionylation of caspase-1 at cysteine residues distal to the active site of the protease 42 , which could alter inflammasome assembly in a manner analogous to S-nitrosylation. The ability of both reactive oxygen species and NO to modulate IL-1 processing emphasizes the important position of the inflammasome as an integration point for pro-and anti-inflammatory pathways, and highlights the central role of redox signaling in this process. Through the coordination of these signals, unproductive inflammation can be suppressed either by the over-accumulation of superoxide-producing phagocytes or by the emergence of IFN-γ-producing lymphocytes. However, whereas the inhibition of IL-1 mediated by reactive oxygen species and that mediated by NO share many similarities, the specificity of NO for the NLRP3 inflammasome suggests that the outcome of this regulation is distinct. The specificity of NO-mediated inhibition indicates that nitrosylation affects only a discrete set of inflammatory states that depend on NLRP3. These include not only chronic bacterial infection in which membrane perturbation is the main inducer of IL-1 but also sterile inflammatory lesions initiated by indigestible particles. We note that the administration of NO has been shown to ameliorate the inflammatory disease promoted by either chronic pulmonary infection 43 or the deposition of cholesterol crystals 44 , and our observations suggest a mechanism to explain this therapeutic effect.
It has been difficult to reconcile the importance of the inflammasome in M. tuberculosis-infected macrophages with its apparent dispensability in mice. Pubished reports have shown that the NLRP3 inflammasome is essential for the processing of IL-1β in macrophages, but caspase-1-independent mechanisms seem to dominate during chronic infection in mice [23] [24] [25] . Our observations have provided an explanation for this apparent paradox. Only in the absence of iNOS did we detect a contribution of the inflammasome in M. tuberculosis-infected mice. Such findings suggest that caspase-1-activating signals are produced during infection but inflammasome complexes are not formed because of the inhibitory effect of NO.
Although we found that IFN-γ and NO inhibited the processing of IL-1β, the mechanisms by which these molecules modulate inflammation probably extend beyond the simple inhibition of inflammasome activity. IFN-γ has been proposed to serve an antiinflammatory role during infection with M. tuberculosis through the modulation of the T H 17 subset of helper T cells or through direct effects on neutrophil survival 45 . In addition, we observed that mutation of Nos2 resulted in a greater abundance of pro-IL-1β in the lungs of M. tuberculosis-infected mice, which suggested that NO might also influence pro-IL-1β expression. Despite the presence of these alternative mechanisms, our observation that ASC was required for the excessive inflammation noted after inhibition of iNOS indicated that the modulation of inflammasome activity has an important if not singular role in mediating the anti-inflammatory effects of IFN-γ and NO.
In the context of infection with M. tuberculosis, we found that the ability of NO to suppress granulocytic inflammation was distinct from its antibacterial function and that both activities seemed to be essential for controlling disease. The immunomodulatory activity of NO emphasizes the coordination required for balancing the competing needs for appropriate antimicrobial responses and preservation of the delicate pulmonary architecture. IL-1β has a central role in this balance during infection with M. tuberculosis as both a mediator of antimycobacterial immunity 46 and a driver of tissue damage. M. tuberculosis causes a wide spectrum of diseases, and many proinflammatory and anti-inflammatory pathways, including those independent of IL-1, could contribute to pathology. Indeed, the balance between the proinflammatory leukotriene LTB4 and the antiinflammatory lipoxin LXA4 may alter the outcome of tuberculosis disease by modulating TNF 47 . As we have suggested for IL-1β, it has been proposed that TNF must be maintained at an optimal concentration to prevent bacterial overgrowth or excess immunopathology. LXA4 has been shown both to inhibit TNF secretion and to induce NO production. Our observation that NO inhibited IL-1 production suggests a possible mechanism by which eicosanoids could coordinately regulate both of these proinflammatory cytokines to minimize tissue damage. The emerging importance of anti-inflammatory mediators such as NO and LXA4 in host resistance to M. tuberculosis indicates that immunomodulatory pathways are an important determinant of disease progression that could be manipulated to prevent tuberculosis disease. Indeed, supplementation with l-arginine, the substrate for iNOS, has been shown to increase NO production and improve the clinical outcome of human immunodeficiency virus-negative patients with tuberculosis who are undergoing chemotherapy 48 . Thus, NO donors or IL-1 antagonists may represent useful adjuncts to therapy against tuberculosis, which could ameliorate the inflammatory tissue damage that occurs during lengthy antimycobacterial treatment regimens.
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